SJ, H., A, P., A, A., D, S., MC, W., A, S., . . . P, R. (2021). Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics. British journal of haematology, 194(1), 120. https://doi.org/10.1111/bjh.17499
Chicago Style (17th ed.) CitationSJ, Harrison, et al. "Subgroup Analysis of ICARIA-MM Study in Relapsed/refractory Multiple Myeloma Patients with High-risk Cytogenetics." British Journal of Haematology 194, no. 1 (2021): 120. https://doi.org/10.1111/bjh.17499.
MLA (9th ed.) CitationSJ, Harrison, et al. "Subgroup Analysis of ICARIA-MM Study in Relapsed/refractory Multiple Myeloma Patients with High-risk Cytogenetics." British Journal of Haematology, vol. 194, no. 1, 2021, p. 120, https://doi.org/10.1111/bjh.17499.